Business Description
Algorae Pharmaceuticals Ltd
ISIN : AU0000296022
Total Employee Number:
48Description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 30.7 | |||||
3-Year EPS without NRI Growth Rate | 20.6 | |||||
3-Year Book Growth Rate | -30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.24 | |||||
9-Day RSI | 36.21 | |||||
14-Day RSI | 36.82 | |||||
3-1 Month Momentum % | -29.41 | |||||
6-1 Month Momentum % | -14.29 | |||||
12-1 Month Momentum % | 140 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 18.03 | |||||
Quick Ratio | 18.03 | |||||
Cash Ratio | 16.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9 | |||||
Shareholder Yield % | -0.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -46.73 | |||||
ROA % | -43.85 | |||||
ROIC % | -5291.49 | |||||
3-Year ROIIC % | -1364.27 | |||||
ROC (Joel Greenblatt) % | -28528.57 | |||||
ROCE % | -92.03 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 10 | |||||
EV-to-EBIT | -9.2 | |||||
EV-to-EBITDA | -9.2 | |||||
EV-to-FCF | -29.02 | |||||
Earnings Yield (Greenblatt) % | -10.87 | |||||
FCF Yield % | -3.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Algorae Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.001 | ||
| Beta | -0.1861 | ||
| 3-Year Sharpe Ratio | 0.31 | ||
| 3-Year Sortino Ratio | 0.63 | ||
| Volatility % | 100.66 | ||
| 14-Day RSI | 36.82 | ||
| 14-Day ATR (A$) | 0.000795 | ||
| 20-Day SMA (A$) | 0.0111 | ||
| 12-1 Month Momentum % | 140 | ||
| 52-Week Range (A$) | 0.005 - 0.024 | ||
| Shares Outstanding (Mil) | 2,025.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Algorae Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Algorae Pharmaceuticals Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Algorae Pharmaceuticals Ltd Frequently Asked Questions
What is Algorae Pharmaceuticals Ltd(ASX:1AI)'s stock price today?
The current price of ASX:1AI is A$0.01. The 52 week high of ASX:1AI is A$0.02 and 52 week low is A$0.01.
When is next earnings date of Algorae Pharmaceuticals Ltd(ASX:1AI)?
The next earnings date of Algorae Pharmaceuticals Ltd(ASX:1AI) is .
Does Algorae Pharmaceuticals Ltd(ASX:1AI) pay dividends? If so, how much?
Algorae Pharmaceuticals Ltd(ASX:1AI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Algorae Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers